Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 2011 Feb 03; 117(5):1662-9.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Chemokine CCL3
Chemokine CCL4
Disease Progression
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
Gene Expression Regulation, Leukemic
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Prognosis
Survival Rate
ZAP-70 Protein-Tyrosine Kinase
authors with profiles
Donna S. Neuberg, D.Sc.